Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?
<p>After starting in China four months ago, the COVID-19 pandemic now affects most countries and has already caused more than 200,000 deaths by April 26, 2020</p><p>Under chest computerized tomography scans, the majority of severe COVID-19 patients show bilateral ground glass-like...
Сохранить в:
Главный автор: | Christian A Devaux (Автор) |
---|---|
Формат: | |
Опубликовано: |
Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,
2020-05-05.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
-
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
по: Geert Byttebier, и др.
Опубликовано: (2021) -
Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function?
по: Cody Carson, и др.
Опубликовано: (2016) -
Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
по: Elena Raccuglia, и др.
Опубликовано: (2009) -
Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study
по: Ahmed A. Alrashed, и др.
Опубликовано: (2021) -
Student Evaluation of Teaching: More Harm than Good?
по: M. O. Abramova, и др.
Опубликовано: (2023)